Product image of Breyanzi (Lisocabtagene Maraleucel) supplied by GNH India

Breyanzi

Active Ingredient:
Lisocabtagene Maraleucel
Origin:
EU

Breyanzi (Lisocabtagene Maraleucel)

Breyanzi is a CAR T-cell therapy used for certain types of cancer. This innovative treatment harnesses the body's immune system to target and destroy cancer cells.

Manufacturer / TM Owner

Bristol-Myers Squibb Pharma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Breyanzi is primarily used in the treatment of specific cancers, such as large B-cell lymphoma. This therapy involves modifying a patient's own T-cells to recognize and attack cancer cells. Patients often wonder, 'What is Breyanzi used for?' It is designed for those who have not responded to other treatments or have relapsed.

Side Effects

  • Breyanzi can cause various effects, including fever, fatigue, and low blood cell counts. These effects are part of the body's response to the therapy and are managed by healthcare professionals. Patients may also experience chills, nausea, or difficulty breathing.

Precautions & Warnings

  • Breyanzi should be administered under strict medical supervision. Patients should be monitored for severe reactions, such as cytokine release syndrome or neurological events. It is crucial to discuss all medical conditions and medications with a healthcare provider before starting treatment.

Avoid Interactions

  • Breyanzi may interact with other medications, including those that affect the immune system. Patients should avoid receiving live vaccines during and after treatment. Alcohol and certain supplements may also interact with this therapy, so it is important to consult a healthcare provider.

Frequently Asked Questions

Breyanzi is used for the treatment of certain types of cancer, particularly large B-cell lymphoma, in patients who have not responded to other treatments.

Breyanzi is administered intravenously by healthcare professionals in a controlled medical setting.

Common side effects include fever, fatigue, low blood cell counts, chills, nausea, and difficulty breathing.

Breyanzi may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Breyanzi should be administered under strict medical supervision, and patients should be monitored for severe reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lisocabtagene Maraleucel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT